Heading Into Earnings, Expectations Are Rising For These 4 Biotech Stocks

Heading into an earnings season in which many companies will be posting much lower earnings as a result of the pandemic, the author of today’s article advises that “One area that can offer some defensive strategies is biotech and pharmaceuticals” – and he highlights four biotech stocks that are currently profitable and seeing rising expectations and targets from Wall Street heading into earnings. For more, CLICK HERE.